Animal Cell Therapies Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $2.85M

  • Investors
  • 1

Animal Cell Therapies General Information

Description

Developer of stem cell treatments designed for acute and chronic diseases in companion animals. The company offers a standardized umbilical cord tissue-derived mesenchymal stem cell product that can be administered in an outpatient setting, enabling pet owners to prevent their pets from orthopedic and other chronic disease conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 302 Enterprise Street
  • Suite A/B
  • Escondido, CA 92029
  • United States
+1 (858)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 302 Enterprise Street
  • Suite A/B
  • Escondido, CA 92029
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Animal Cell Therapies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 22-Apr-2021 $2.85M Completed Generating Revenue
5. Later Stage VC 16-Jul-2019 Completed Generating Revenue
4. Later Stage VC 28-Jan-2015 Completed Generating Revenue
3. Grant 10-Jul-2013 Completed Generating Revenue
2. Early Stage VC 01-Dec-2010 $675K $1.88M Completed Generating Revenue
1. Early Stage VC (Series A) 27-Aug-2009 $1.2M $1.2M Completed Generating Revenue
To view Animal Cell Therapies’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Animal Cell Therapies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of stem cell treatments designed for acute and chronic diseases in companion animals. The company offers a sta
Drug Discovery
Escondido, CA
6 As of 2025

San Diego, CA
 

Los Angeles, CA
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Animal Cell Therapies Competitors (7)

One of Animal Cell Therapies’s 7 competitors is Stemedica, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Stemedica Venture Capital-Backed San Diego, CA
Moraga Biotechnology Corporation Corporation Los Angeles, CA
AVM Biotechnology Private Equity-Backed Seattle, WA
Cerenome Corporation Houston, TX
VetStem Corporation Poway, CA
You’re viewing 5 of 7 competitors. Get the full list »

Animal Cell Therapies Patents

Animal Cell Therapies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20200046776-A1 Stem cells and methods of using them Inactive 09-Aug-2018
US-20170368109-A1 Probiotic fermentation products Inactive 28-Jun-2016
US-20140120068-A1 Solutions, systems and methods for cell, tissue and organ preservation Inactive 01-Nov-2012
US-20130196935-A1 Synthetic glycoamine compounds Inactive 27-Jan-2012 A61K45/06

Animal Cell Therapies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Animal Cell Therapies Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Sabes Family Foundation Corporation
To view Animal Cell Therapies’s complete investors history, request access »

Animal Cell Therapies FAQs

  • When was Animal Cell Therapies founded?

    Animal Cell Therapies was founded in 2008.

  • Where is Animal Cell Therapies headquartered?

    Animal Cell Therapies is headquartered in Escondido, CA.

  • What is the size of Animal Cell Therapies?

    Animal Cell Therapies has 6 total employees.

  • What industry is Animal Cell Therapies in?

    Animal Cell Therapies’s primary industry is Drug Discovery.

  • Is Animal Cell Therapies a private or public company?

    Animal Cell Therapies is a Private company.

  • What is Animal Cell Therapies’s current revenue?

    The current revenue for Animal Cell Therapies is .

  • How much funding has Animal Cell Therapies raised over time?

    Animal Cell Therapies has raised $13.4M.

  • Who are Animal Cell Therapies’s investors?

    The Sabes Family Foundation has invested in Animal Cell Therapies.

  • Who are Animal Cell Therapies’s competitors?

    Stemedica, Moraga Biotechnology Corporation, AVM Biotechnology, Cerenome, and VetStem are some of the 7 competitors of Animal Cell Therapies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process